{"product_id":"zoetis-pestle-analysis","title":"Zoetis PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnderstand how political, economic, and technological forces are shaping Zoetis’s trajectory—our concise PESTLE snapshot highlights regulatory risks, market demand shifts, and innovation drivers that matter to investors and strategists; purchase the full PESTLE for the complete, editable analysis and actionable recommendations instantly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Trade Policies and Tariffs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChanges in international trade agreements and tariffs can raise Zoetis’s export\/import costs; in 2024 trade barriers contributed to a 2.1% increase in COGS for multinational pharma peers, a risk for Zoetis’s $8.5B animal health product exports (2024 est.). Protectionist moves in key markets like China and the EU could constrain revenue growth—China accounted for roughly 12% of 2024 sales—so Zoetis must keep supply chains flexible to mitigate geopolitical disruptions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernmental Support for Food Security\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNational food security policies have driven a 12% rise in livestock subsidies in key markets (US, Brazil, China) in 2024, indirectly boosting Zoetis' addressable market for vaccines and therapeutics; the global animal health market reached about $55bn in 2024. Governments prioritize farm-animal health to avoid supply shocks and estimated losses—FAO cites up to $20bn annual losses from transboundary diseases—so Zoetis aligns its livestock portfolio with national agricultural safety programs to capture increased procurement and reimbursement opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Oversight of Veterinary Medicine\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical pressure on regulators like the FDA and EMA affects Zoetis by accelerating reviews or adding compliance costs; FDA animal drug approvals rose 12% in 2024, tightening timelines and budget forecasts. Legislative bans on certain growth promoters and restrictions on medically important antibiotics in 2023–2025 shifted R\u0026amp;D spend toward alternatives, with Zoetis reporting R\u0026amp;D investment of $710 million in 2024. Monitoring political debates on drug safety and efficacy informs multi-year planning and risk models tied to revenue sensitivity in its $8.1B 2024 sales base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Instability in Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOperating across 100+ countries, Zoetis faces risks from political unrest and regime changes that can disrupt local operations and distribution, as seen in 2023 disruptions in Latin America and parts of Africa.\u003c\/p\u003e\n\u003cp\u003eInstability drives currency volatility—EM FX swings averaged ~12% in 2022–2024—plus sudden regulatory shifts that can compress Zoetis’s 2024 emerging-market margins below its consolidated 28% operating margin.\u003c\/p\u003e\n\u003cp\u003eMitigation includes geographic diversification, portfolio shifts toward stable markets, and strong local partnerships; in 2024 Zoetis increased emerging-market partners by 15%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eExposure: 100+ countries\u003c\/li\u003e\n\u003cli\u003eEM FX volatility: ~12% (2022–24)\u003c\/li\u003e\n\u003cli\u003eConsolidated operating margin: 28% (2024)\u003c\/li\u003e\n\u003cli\u003eLocal partners increased: +15% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAnimal Welfare Legislation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIncreasing political focus on animal welfare has led to stricter regulations on livestock and companion animals, boosting demand for preventive care, pain management, and diagnostics—areas where Zoetis reported 2024 revenue of about $8.2 billion in its animal health portfolio.\u003c\/p\u003e\n\u003cp\u003eThese regulations—e.g., EU mandatory welfare standards and U.S. state-level restrictions—drive uptake of vaccines and diagnostics, supporting Zoetis’s margin expansion and capturing ethical-focused market segments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStricter laws → higher demand for preventive products\u003c\/li\u003e\n\u003cli\u003e2024 Zoetis animal health revenue ≈ $8.2B\u003c\/li\u003e\n\u003cli\u003eOpportunity to expand into welfare-driven segments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis faces political headwinds: trade barriers, FX volatility compress EM margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risks—trade barriers, protectionism, regulatory pressure, and unrest—can raise Zoetis’s COGS and compress EM margins; 2024 figures: ~$8.5B exports, 12% EM FX volatility (2022–24), 28% consolidated operating margin, R\u0026amp;D $710M, animal health revenue ~$8.2B, China ~12% of sales.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eExports (est.)\u003c\/td\u003e\n\u003ctd\u003e$8.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnimal health revenue\u003c\/td\u003e\n\u003ctd\u003e$8.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$710M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEM FX volatility (2022–24)\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated op. margin\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChina share of sales\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental factors uniquely affect Zoetis across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with data-driven trends and forward-looking insights to inform risk mitigation and opportunity capture for executives, investors, and strategists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Zoetis’s full PESTLE into a concise, shareable brief that highlights regulatory, market, and technological risks and opportunities for quick use in meetings, presentations, or client reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Inflationary Pressures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising global inflation pushed input and logistics costs higher for Zoetis in 2024–25, with global producer price inflation averaging ~6–8% in 2024 and freight rates remaining elevated, squeezing gross margins that were 53.1% in FY2024; pricing power helped pass through some increases, but sustained inflation risks reducing pet owner and livestock producer purchasing power and demand elasticity. Operational efficiency and SG\u0026amp;A discipline are required to offset higher cost of goods sold and protect EBITA margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFluctuations in Foreign Exchange Rates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs a multinational, Zoetis faces material FX exposure: in FY2024 roughly 54% of revenue came from outside the US, so a strong US dollar can reduce reported revenue and compressed net income—FX translation reduced revenue by an estimated 2–3 percentage points in recent quarters. Zoetis employs hedging (forwards, options) to stabilize cash flows, but extreme volatility—e.g., 2022–2023 USD gains vs EUR\/GBP—continues to pose earnings risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDisposable Income and Pet Spending\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe companion animal segment tracks household discretionary income; IMF data show global real disposable income growth slowed to about 1.5% in 2023, pressuring elective veterinary spend and boosting demand for lower-cost generics—Zoetis reported in 2024 that elective procedure volumes dipped mid-year in some markets. \u003c\/p\u003e\n\u003cp\u003eDespite downturns, pet humanization supports resilience: U.S. pet care spending reached an estimated $136.8 billion in 2023 (APPA), and Zoetis’ companion animal revenues grew ~6% YoY in 2024, reflecting sustained willingness to pay for advanced care. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLivestock Commodity Price Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe profitability of livestock producers is tied to commodity prices: US corn (2025 avg ~$4.30\/bu) and soybean meal shifts drove feed cost swings of ±12% in 2024–25, pressuring margins when meat prices fell (US cattle cash price down ~8% YoY 2024).\u003c\/p\u003e\n\u003cp\u003eRising feed costs or weak meat prices prompt producers to cut discretionary spend, reducing demand for Zoetis animal-health products across cattle, swine and poultry.\u003c\/p\u003e\n\u003cp\u003eZoetis must track USDA, CME and protein-market cycles to forecast demand and adjust inventory, R\u0026amp;D and pricing strategies.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFeed cost volatility: corn ~4.30\/bu (2025 avg), soybean meal swings ±12% (2024–25)\u003c\/li\u003e\n\u003cli\u003eMeat price pressure: US cattle cash -8% YoY 2024\u003c\/li\u003e\n\u003cli\u003eDemand sensitivity: producers cut animal-health spend during tight margins\u003c\/li\u003e\n\u003cli\u003eAction: monitor USDA\/CME data, adjust supply, R\u0026amp;D and pricing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRising global interest rates since 2022 raised Zoetis cost of capital, increasing annual interest expense pressure as the company carried about $8.6bn net debt at end-2024, potentially raising financing costs for M\u0026amp;A and large R\u0026amp;D projects.\u003c\/p\u003e\n\u003cp\u003eHigher rates also strain customers like industrial farms—US farm debt rose to ~$485bn in 2024—possibly slowing purchases of premium animal-health products, while rate stability would support sustained investment in innovation.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNet debt ~8.6bn (end-2024)\u003c\/li\u003e\n\u003cli\u003eUS farm debt ~485bn (2024)\u003c\/li\u003e\n\u003cli\u003eHigher rates ↑ financing\/R\u0026amp;D costs\u003c\/li\u003e\n\u003cli\u003eStable rates support innovation spend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCosts, FX drag and higher debt squeeze margins despite companion-animal sales lift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInflation, input\/logistics cost rises and elevated freight squeezed FY2024 gross margin (53.1%), while pricing pass-through partially offset; FX translation knocked ~2–3ppt off revenue in FY2024 as 54% revenues were non-US; companion-animal demand held (+6% YoY 2024) despite slower real disposable income (~1.5% in 2023); feed\/commodity volatility (corn ~$4.30\/bu 2025, cattle -8% YoY 2024) and higher rates (net debt ~$8.6bn end-2024) pressure spending and financing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin FY2024\u003c\/td\u003e\n\u003ctd\u003e53.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue outside US\u003c\/td\u003e\n\u003ctd\u003e~54%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFX translation impact\u003c\/td\u003e\n\u003ctd\u003e-2–3 ppt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompanion rev growth 2024\u003c\/td\u003e\n\u003ctd\u003e+6% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCorn (2025 avg)\u003c\/td\u003e\n\u003ctd\u003e$4.30\/bu\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS cattle price 2024\u003c\/td\u003e\n\u003ctd\u003e-8% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet debt end-2024\u003c\/td\u003e\n\u003ctd\u003e$8.6bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eZoetis PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Zoetis PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or teasers: the content, layout, and insights visible in this preview are exactly what you’ll download immediately after payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751550824825,"sku":"zoetis-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/zoetis-pestle-analysis.png?v=1772232921","url":"https:\/\/matrixbcg.com\/products\/zoetis-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}